MEDSENIC
Medsenic is a privately held company that manufactures drugs for the treatment of autoimmune diseases.
MEDSENIC
Industry:
Biotechnology Manufacturing
Founded:
2010-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.medsenic.com
Total Employee:
1+
Status:
Active
Total Funding:
2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
PharMida
PharMida is a Basel-based drug development company.
Serodus
Serodus ASA is a private Scandinavian drug development company.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cap Innov'Est
Cap Innov'Est investment in Venture Round - Medsenic
FaDièse
FaDièse investment in Venture Round - Medsenic
Investisseurs & Partenaires
Investisseurs & Partenaires investment in Venture Round - Medsenic
Official Site Inspections
http://www.medsenic.com Semrush global rank: 5.19 M Semrush visits lastest month: 1.56 K
- Host name: vm645.haisoft.net
- IP address: 91.212.26.145
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Medsenic"
Medsenic SAS
Fondée en 2010, MEDSENIC est une Biotech qui a pour vocation d’exploiter des nouvelles cibles thérapeutiques à base de trioxyde d’arsenic (As2O3) pour fournir un traitement efficace aux …See details»
Medsenic SAS
Founded in 2010, MEDSENIC is a biotech dedicated to exploiting novel therapeutic targets based on arsenic trioxide (As2O3) to provide effective treatment for patients suffering from autoimmune diseases.See details»
Medsenic - Crunchbase Company Profile & Funding
Medsenic is a privately held company that manufactures drugs for the treatment of autoimmune diseases. Medsenic merged with BioSenic on Oct 27, 2022. Where is Medsenic's …See details»
Home | BioSenic
BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products. All regulatory information and reports. Discover all the …See details»
MEDSENIC - LinkedIn
Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a …See details»
Bone Therapeutics merges with Medsenic and changes …
Oct 25, 2022 · Bone Therapeutics has merged with French inflammatory/autoimmune company Medsenic in a €40m deal and changed its name into BioSenic.See details»
Medsenic Company Profile - Office Locations, Competitors ... - Craft
Medsenic is a biopharmaceutical company that develops treatment for patients with auto diseases-immune. It creates drugs utilizing arsenic trioxide (As2O3) for treating diseases such …See details»
Medsenic, BioSenic’s subsidiary, signed a new set of licensing and ...
Jul 2, 2024 · BioSenic is a leading biotech company specializing in the development of clinical assets issued from its Medsenic’s arsenic trioxide (ATO) platform. Key target indications for …See details»
Bone Therapeutics completes the acquisition of Medsenic and …
Oct 25, 2022 · Bone Therapeutics the cell therapy company addressing unmet medical needs in orthopedics and other diseases, announces the closing of its acquisition of a majority …See details»
Medsenic reverse merger with Bone Therapeutics to access public ...
Medsenic innovates and exploits the new possibilities offered by the therapeutic use of arsenic trioxide in several autoimmune diseases and is currently in clinical trials in Europe.See details»
MEDSENIC Company Profile | STRASBOURG, GRAND EST, France
MEDSENIC Company Profile | STRASBOURG, GRAND EST, France | Competitors, Financials & Contacts - Dun & BradstreetSee details»
About Us - BioSenic
BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of innate immunity, inflammation and organ/function repair. Our expertise is …See details»
Bone Therapeutics to broaden and derisk therapeutic
Sep 8, 2022 · Integrating both biopharmaceutical companies would significantly derisk and broaden Bone Therapeutic's therapeutic portfolio, targeting a broad array of inflammatory and …See details»
Medsenic - Products, Competitors, Financials, Employees, …
It offers treatment facilities for diseases such as systemic lupus erythematosus, systemic sclerosis, and chronic graft-versus-host disease. The company was founded in 2010 and is …See details»
Medsenic, subsidiary of BioSenic SA, extends key patent to the …
Jul 5, 2024 · Medsenic’s enriched IP portfolio is aimed at protecting medications involving the combination of arsenic trioxide (ATO) and copper ions, which have demonstrated increased …See details»
Bone Therapeutics to merge with Medsenic | medthority.com
Aug 10, 2022 · Integrating both biopharmaceutical companies would significantly derisk and broaden Bone Therapeutic's therapeutic portfolio, targeting a broad array of inflammatory and …See details»
Health & Medicine François Rieger Old medication, new cure?
Professor François Rieger and his colleagues are successfully exploiting the new possibilities offered by the therapeutic use of arsenic salts for the treatment of selected autoimmune …See details»
Medsenic Receives Positive Pre-IND Response from FDA to Initiate …
Jun 21, 2022 · Medsenic is focusing its clinical activities on the development of OATO (oral arsenic trioxide) for the treatment of selected autoimmune diseases. Consequently, …See details»
BioSenic provides third quarter 2024 Business Update - Euronext …
Oct 28, 2024 · Medsenic has been successful in a phase 2 trial with its intravenous formulation, Arscimed®, which has orphan drug designation status by FDA and EMA. The company is …See details»
Biosenic and Phebra PTY Ltd. Finalize an Agreement for …
Jan 16, 2024 · BIOSENIC (Euronext Brussels and Paris: BIOS), a clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, and its …See details»